These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29331961)

  • 1. Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update.
    Derex L; Paris C; Nighoghossian N
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331961
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.
    Bhatt DL
    Nat Rev Cardiol; 2018 Feb; 15(2):71-72. PubMed ID: 29297509
    [No Abstract]   [Full Text] [Related]  

  • 3. Vertebrobasilar thrombolysis with intravenous tirofiban: case report.
    Liebeskind DS; Pollard JR; Schwartz ED; Cucchiara BL; McGarvey ML; Hurst RW
    J Thromb Thrombolysis; 2002 Apr; 13(2):81-4. PubMed ID: 12101384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW; Tsai YT; Chou PC; Chen HM; Lu CM; Tsao CR; Chen CL; Sun MC; Shih YS; Hsieh CY; Chen LA; Chen PL; Yeh JT; Li YH
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
    Verheugt FWA
    Circulation; 2018 Apr; 137(16):1655-1657. PubMed ID: 29661947
    [No Abstract]   [Full Text] [Related]  

  • 6. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe intravenous thrombolysis in acute stroke despite treatment with rivaroxaban.
    Bornkamm K; Harloff A
    J Clin Neurosci; 2014 Nov; 21(11):2012-3. PubMed ID: 24938385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
    Goel S; Pasam RT; Sharma A; Gidwani U
    Cardiovasc Revasc Med; 2020 Feb; 21(2):239-241. PubMed ID: 31718958
    [No Abstract]   [Full Text] [Related]  

  • 9. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
    Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and benefits of early antithrombotic therapy after thrombolytic treatment in patients with acute stroke.
    Amaro S; Llull L; Urra X; Obach V; Cervera Á; Chamorro Á
    PLoS One; 2013; 8(8):e71132. PubMed ID: 23951093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
    Ruiz-Nodar JM; Marín F; Lip GY
    JACC Cardiovasc Interv; 2008 Jun; 1(3):329; author reply 330-1. PubMed ID: 19463322
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
    Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?
    Spinthakis N; Farag M; Akhtar Z; Gorog DA
    Curr Vasc Pharmacol; 2018; 16(5):427-436. PubMed ID: 29345587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic and anticoagulant therapy for atrial fibrillation.
    Dzeshka MS; Lip GY
    Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Therapy After TAVR.
    Geisler T; Droppa M; Muller K; Borst O
    Curr Vasc Pharmacol; 2018; 16(5):437-445. PubMed ID: 29345593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.
    Wong JWP; Churilov L; Dowling R; Mitchell P; Bush S; Kanesan L; Yan B
    Cerebrovasc Dis; 2018; 46(5-6):193-199. PubMed ID: 30384367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Treatment Prior to Intracerebral Hemorrhage: Analysis in the National Acute Stroke Israeli Registry.
    Romem R; Tanne D; Geva D; Einhorn-Cohen M; Shlomo N; Bar-Yehuda S; Harnof S
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3380-3386. PubMed ID: 30205997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on pharma in acute coronary syndrome.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):1-2. PubMed ID: 31909430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.